
Dr Richard Mohs is the chief scientific officer for the Global Alzheimer's Platform Foundation. He is also a consultant to academic institutions, foundations and biopharmaceutical companies, and a member of the board of governors for the Alzheimer's Drug Discovery Foundation.
Dr Mohs retired from Eli Lilly in 2015 where he held leadership positions including vice president for Neuroscience Early Clinical Development and leader of the Global Alzheimer's Drug Development Team. Before joining Eli Lilly, Dr Mohs spent 23 years with the Mount Sinai School of Medicine where he was a Professor in the Department of Psychiatry and Associate Chief of Staff for Research at the Bronx Veterans Affairs Medical Centre.